EQL Pharma AB (publ) (STO:EQL)

EQL Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	772	1,606	2,064	1,229	1,087	974
Market Cap Growth	-66.37%	-22.15%	67.85%	13.10%	11.64%	-2.05%
Enterprise Value	1,134	1,971	2,205	1,317	1,075	1,010
Last Close Price	26.15	54.40	71.00	42.30	37.40	33.50
PE Ratio	62.26	128.12	47.85	54.15	35.15	30.86
PS Ratio	1.78	3.71	5.53	4.65	4.18	2.38
PB Ratio	2.89	6.02	9.34	6.92	7.02	7.88
P/TBV Ratio	-	-	-	42.91	20.82	38.62
P/FCF Ratio	33.70	70.10	-	-	40.02	23.63
P/OCF Ratio	27.23	56.64	-	-	39.36	23.28
EV/Sales Ratio	2.62	4.56	5.90	4.99	4.14	2.47
EV/EBITDA Ratio	16.21	28.17	29.14	33.94	22.70	24.92
EV/EBIT Ratio	23.29	40.48	32.73	40.38	26.01	26.01
EV/FCF Ratio	49.48	86.00	-	-	39.59	24.52
Debt / Equity Ratio	1.68	1.68	2.06	0.68	0.43	0.62
Debt / EBITDA Ratio	6.41	6.41	5.88	2.98	1.37	1.83
Debt / FCF Ratio	19.57	19.57	-	-	2.45	1.85
Net Debt / Equity Ratio	1.35	1.35	1.69	0.56	0.14	0.28
Net Debt / EBITDA Ratio	5.17	5.17	4.93	2.57	0.47	0.86
Net Debt / FCF Ratio	15.78	15.78	-12.13	-8.06	0.82	0.85
Asset Turnover	0.52	0.52	0.63	0.80	0.99	1.86
Inventory Turnover	1.42	1.42	1.53	1.74	2.69	7.47
Quick Ratio	0.97	0.97	0.97	0.53	0.83	0.77
Current Ratio	1.92	1.92	1.81	1.22	1.43	1.25
Return on Equity (ROE)	5.14%	5.14%	21.63%	13.66%	22.21%	29.37%
Return on Assets (ROA)	3.67%	3.67%	7.12%	6.18%	9.87%	11.00%
Return on Invested Capital (ROIC)	5.31%	5.48%	12.26%	11.40%	19.56%	21.96%
Return on Capital Employed (ROCE)	7.60%	7.60%	11.50%	15.40%	24.50%	27.90%
Earnings Yield	1.62%	0.78%	2.09%	1.85%	2.84%	3.24%
FCF Yield	2.97%	1.43%	-1.49%	-1.01%	2.50%	4.23%
Buyback Yield / Dilution	-0.92%	-0.92%	-0.34%	-0.91%	-1.59%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.